Vitamin D Deficiency Clinical Trial
Official title:
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Background:
Vitamin D plays a key role in calcium absorption in the gut and in skeletal development.
Vitamin D deficiency is common, affecting an estimated one billion people worldwide,
including developed countries. Vitamin D deficiency causes rickets, the most common
non-communicable disease of childhood. Rickets causes poor growth and skeletal deformities
and, at its most severe, seizures and death. Recent data suggest that children with rickets
have an increased risk for developing diabetes mellitus.
Screening for vitamin D deficiency is not commonly done. It is generally diagnosed only
after symptoms of rickets have developed. Prevention and treatment is simple and
inexpensive. Hence, early detection of vitamin D deficiency through screening would be
beneficial. Studies are urgently needed to validate such screening tests.
Calcium balance is tightly regulated in the body and calcium loss in the urine (measured by
the urine calcium-to-creatinine ratio) is a sensitive indicator of reduced calcium
absorption, such as in vitamin D deficiency.
Objective and Hypotheses. The objective of this study is to evaluate the urine
calcium-to-creatinine ratio as a noninvasive and inexpensive screening test for vitamin D
deficiency. Our hypotheses are 1) that the urine calcium-to-creatinine ratio correlates with
blood vitamin D levels in infants and toddlers at risk for vitamin D deficiency and 2) that
this test can be used to screen for vitamin D deficiency.
Potential Impact. A validated screening tool would allow for the detection of vitamin D
deficiency before the development of rickets, decreasing the morbidity and mortality of this
common disease.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | July 2011 |
| Est. primary completion date | July 2011 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 6 Months to 3 Years |
| Eligibility |
Inclusion Criteria: - In one of the 6 high-risk groups between the age of 6 months and 3 years. Exclusion Criteria: - known familial rickets (hypophosphatemic or vitamin D resistant) - known parathyroid hormone problems - any child on diuretics - presence of a chronic disease or use of medications known to affect vitamin D metabolism - renal insufficiency - known malabsorption - rickets secondary to other syndromes (e.g. Fanconi syndrome) |
Observational Model: Cohort, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| United States | Nemours Children's Clinic | Jacksonville | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Nemours Children's Clinic |
United States,
Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008 Jun;162(6):505-12. doi: 10.1001/archpedi.162.6.505. — View Citation
Olney RC, Mazur JM, Pike LM, Froyen MK, Ramirez-Garnica G, Loveless EA, Mandel DM, Hahn GA, Neal KM, Cummings RJ. Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890-7. doi: 10.1542/peds.2007-2079. — View Citation
Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Isichei CO, Chan GM. Case-control study of factors associated with nutritional rickets in Nigerian children. J Pediatr. 2000 Sep;137(3):367-73. — View Citation
Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr. 2000 Jun;46(3):132-9. — View Citation
Thacher TD, Fischer PR, Pettifor JM. The usefulness of clinical features to identify active rickets. Ann Trop Paediatr. 2002 Sep;22(3):229-37. — View Citation
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05459298 -
ViDES Trial (Vitamin D Extra Supplementation)
|
N/A | |
| Completed |
NCT04476511 -
The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules
|
Phase 3 | |
| Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
| Completed |
NCT03920150 -
Vitamin D 24'000 IU for Oral Intermittent Supplementation
|
Phase 3 | |
| Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
| Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
| Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
| Completed |
NCT05506696 -
Vitamin D Supplementation Study
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Completed |
NCT03234218 -
Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
|
||
| Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
| Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
| Completed |
NCT02906319 -
Vitamin D and HbA1c Levels in Diabetic Patients With CKD
|
N/A | |
| Completed |
NCT02118129 -
Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.
|
N/A | |
| Completed |
NCT02275650 -
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
|
N/A | |
| Completed |
NCT02187146 -
The Effects of Serum Vitamin D and IVF Outcome
|
N/A | |
| Not yet recruiting |
NCT01419821 -
Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
|
N/A | |
| Completed |
NCT01688102 -
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
|
N/A | |
| Completed |
NCT01651000 -
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
|
Phase 3 |